NAGE

Niagen Bioscience, Inc. Common Stock

64 hedge funds and large institutions have $40.9M invested in Niagen Bioscience, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
Holders Change %
0%
% of All Funds
1.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
20
Reduced
12
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Legal & General Group
51
Legal & General Group
United Kingdom
$25K
OGC
52
Oak Grove Capital
New Hampshire
$21K
OIA
53
OneDigital Investment Advisors
Kansas
$17K
PCA
54
Peddock Capital Advisors
Massachusetts
$15K
AIP
55
Ameritas Investment Partners
Nebraska
$14K
Simplex Trading
56
Simplex Trading
Illinois
$14K +$14K +3,264 New
HS
57
Horan Securities
United States
$8K
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$5.4K -$34 -8 -0.6%
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$5K +$2.26K +533 +82%
RE
60
RBC Europe
United Kingdom
$3.3K
AA
61
AlphaMark Advisors
Kentucky
$3K
VFA
62
Valeo Financial Advisors
Indiana
$2K
TRCT
63
Tower Research Capital (TRC)
New York
$1K -$2.78K -614 -74%
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$1K -$26 -7 -3%
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
-$55K -14,886 Closed
PNC Financial Services Group
66
PNC Financial Services Group
Pennsylvania
-$48K -13,000 Closed
CS
67
Credit Suisse
Switzerland
-$48K -12,840 Closed
S
68
SignatureFD
Georgia
-$30K -8,000 Closed
CPA
69
Cowen Prime Advisors
New York
-$8K -2,200 Closed
MAM
70
Meeder Asset Management
Ohio
-$5.55K -1,495 Closed
PIA
71
Piedmont Investment Advisors
North Carolina
-$2K -668 Closed